Detalles de la búsqueda
1.
Drug-Eluting Resorbable Scaffold versus Angioplasty for Infrapopliteal Artery Disease.
N Engl J Med
; 390(1): 9-19, 2024 Jan 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-37888915
2.
Lenvatinib plus Pembrolizumab or Everolimus for Advanced Renal Cell Carcinoma.
N Engl J Med
; 384(14): 1289-1300, 2021 04 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-33616314
3.
Impact of Everolimus Initiation and Corticosteroid Weaning During Acute Phase After Heart Transplantation on Clinical Outcome: Data from the Korean Organ Transplant Registry (KOTRY).
Transpl Int
; 37: 11878, 2024.
Artículo
en Inglés
| MEDLINE | ID: mdl-38644935
4.
Cutting Edge: mTORC1 Inhibition in Metastatic Breast Cancer Patients Negatively Affects Peripheral NK Cell Maturation and Number.
J Immunol
; 206(10): 2265-2270, 2021 05 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-33931486
5.
Reinduction therapy with everolimus in combination with dexamethasone, high-dose cytarabin and cisplatinum in patients with relapsed or refractory classical Hodgkin lymphoma: an experimental phase I/II multicentre trial of the German Hodgkin Study Group (GHSG HD-R3i).
Br J Haematol
; 196(3): 606-616, 2022 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-34775591
6.
Five-Year Outcomes after PCI or CABG for Left Main Coronary Disease.
N Engl J Med
; 381(19): 1820-1830, 2019 11 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-31562798
7.
Rapalogs induce non-apoptotic, autophagy-dependent cell death in HPV-negative TP53 mutant head and neck squamous cell carcinoma.
Mol Carcinog
; 61(1): 33-44, 2022 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-34598317
8.
Real-Life Analysis of Efficacy and Safety of Everolimus Plus Exemestane in Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor-2-Negative Metastatic Breast Cancer Patients: A Turkish Oncology Group (TOG) Study.
Cancer Invest
; 40(2): 199-209, 2022 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-34894960
9.
Case series of coronary artery aneurysms after Everolimus eluting stent implantation and comparison with Sirolimus eluting stents.
BMC Cardiovasc Disord
; 22(1): 60, 2022 02 17.
Artículo
en Inglés
| MEDLINE | ID: mdl-35172738
10.
Steering Transplant Immunosuppression by Measuring Virus-Specific T Cell Levels: The Randomized, Controlled IVIST Trial.
J Am Soc Nephrol
; 32(2): 502-516, 2021 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-33323473
11.
Long-Term Safety and Efficacy of Durable Polymer Cobalt-Chromium Everolimus-Eluting Stents in Patients at High Bleeding Risk: A Patient-Level Stratified Analysis From Four Postapproval Studies.
Circulation
; 141(11): 891-901, 2020 03 17.
Artículo
en Inglés
| MEDLINE | ID: mdl-31992063
12.
A phase Ib/II study of xentuzumab, an IGF-neutralising antibody, combined with exemestane and everolimus in hormone receptor-positive, HER2-negative locally advanced/metastatic breast cancer.
Breast Cancer Res
; 23(1): 8, 2021 01 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-33451345
13.
Patterns of treatment with everolimus exemestane in hormone receptor-positive HER2-negative metastatic breast cancer in the era of targeted therapy.
Breast Cancer Res
; 23(1): 14, 2021 01 29.
Artículo
en Inglés
| MEDLINE | ID: mdl-33514405
14.
Everolimus after failure of one prior VEGF-targeted therapy in metastatic renal cell carcinoma: Final results of the MARC-2 trial.
Int J Cancer
; 148(7): 1685-1694, 2021 04 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-33070307
15.
Correlative serum biomarker analyses in the phase 2 trial of lenvatinib-plus-everolimus in patients with metastatic renal cell carcinoma.
Br J Cancer
; 124(1): 237-246, 2021 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-33024271
16.
Design and rationale of the XIENCE short DAPT clinical program: An assessment of the safety of 3-month and 1-month DAPT in patients at high bleeding risk undergoing PCI with an everolimus-eluting stent.
Am Heart J
; 231: 147-156, 2021 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-33031789
17.
Significant benefit of everolimus in a patient with urothelial bladder cancer harboring a rare M1043I mutation of PIK3CA.
Invest New Drugs
; 39(4): 1197-1199, 2021 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-33745098
18.
Phase II Study of Single-Agent and Combination Everolimus and Panobinostat in Relapsed or Refractory Diffuse Large B-Cell Lymphoma.
Cancer Invest
; 39(10): 871-879, 2021 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-34643126
19.
Secondary endpoints analysis in patients with estrogen receptor-positive metastatic breast cancer treated with everolimus and exemestane enrolled in Oral Care-BC.
BMC Cancer
; 21(1): 34, 2021 Jan 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-33413212
20.
Neoadjuvant everolimus plus letrozole versus fluorouracil, epirubicin and cyclophosphamide for ER-positive, HER2-negative breast cancer: a randomized pilot trial.
BMC Cancer
; 21(1): 862, 2021 Jul 27.
Artículo
en Inglés
| MEDLINE | ID: mdl-34315439